371 related articles for article (PubMed ID: 2452688)
1. Transcriptional control of high molecular weight keratin gene expression in multistage mouse skin carcinogenesis.
Roop DR; Krieg TM; Mehrel T; Cheng CK; Yuspa SH
Cancer Res; 1988 Jun; 48(11):3245-52. PubMed ID: 2452688
[TBL] [Abstract][Full Text] [Related]
2. Ornithine decarboxylase expression in cutaneous papillomas in SENCAR mice is associated with altered expression of keratins 1 and 10.
Sundberg JP; Erickson AA; Roop DR; Binder RL
Cancer Res; 1994 Mar; 54(5):1344-51. PubMed ID: 7509717
[TBL] [Abstract][Full Text] [Related]
3. Keratin gene expression in mouse skin tumors and in mouse skin treated with 12-O-tetradecanoylphorbol-13-acetate.
Toftgard R; Yuspa SH; Roop DR
Cancer Res; 1985 Nov; 45(11 Pt 2):5845-50. PubMed ID: 2414001
[TBL] [Abstract][Full Text] [Related]
4. The suprabasal expression of alpha 6 beta 4 integrin is associated with a high risk for malignant progression in mouse skin carcinogenesis.
Tennenbaum T; Weiner AK; Belanger AJ; Glick AB; Hennings H; Yuspa SH
Cancer Res; 1993 Oct; 53(20):4803-10. PubMed ID: 8402665
[TBL] [Abstract][Full Text] [Related]
5. Sequential development of aneuploidy, keratin modifications, and gamma-glutamyltransferase expression in mouse skin papillomas.
Aldaz CM; Conti CJ; Larcher F; Trono D; Roop DR; Chesner J; Whitehead T; Slaga TJ
Cancer Res; 1988 Jun; 48(11):3253-7. PubMed ID: 2452689
[TBL] [Abstract][Full Text] [Related]
6. Changes in keratin expression during 7,12-dimethylbenz[a]anthracene-induced hamster cheek pouch carcinogenesis.
Gimenez-Conti IB; Shin DM; Bianchi AB; Roop DR; Hong WK; Conti CJ; Slaga TJ
Cancer Res; 1990 Jul; 50(14):4441-5. PubMed ID: 1694722
[TBL] [Abstract][Full Text] [Related]
7. PTEN loss promotes rasHa-mediated papillomatogenesis via dual up-regulation of AKT activity and cell cycle deregulation but malignant conversion proceeds via PTEN-associated pathways.
Yao D; Alexander CL; Quinn JA; Porter MJ; Wu H; Greenhalgh DA
Cancer Res; 2006 Feb; 66(3):1302-12. PubMed ID: 16452183
[TBL] [Abstract][Full Text] [Related]
8. Mouse skin tumor progression results in differential expression of retinoic acid and retinoid X receptors.
Darwiche N; Celli G; Tennenbaum T; Glick AB; Yuspa SH; De Luca LM
Cancer Res; 1995 Jul; 55(13):2774-82. PubMed ID: 7540949
[TBL] [Abstract][Full Text] [Related]
9. Keratin modifications in epidermis, papillomas, and carcinomas during two-stage carcinogenesis in the SENCAR mouse.
Nelson KG; Slaga TJ
Cancer Res; 1982 Oct; 42(10):4176-81. PubMed ID: 6179598
[TBL] [Abstract][Full Text] [Related]
10. Development of an in vitro model to study carcinogen-induced neoplastic progression of initiated mouse epidermal cells.
Morgan D; Welty D; Glick A; Greenhalgh D; Hennings H; Yuspa SH
Cancer Res; 1992 Jun; 52(11):3145-56. PubMed ID: 1375535
[TBL] [Abstract][Full Text] [Related]
11. Influence of beta1 integrins on epidermal squamous cell carcinoma formation in a transgenic mouse model: alpha3beta1, but not alpha2beta1, suppresses malignant conversion.
Owens DM; Watt FM
Cancer Res; 2001 Jul; 61(13):5248-54. PubMed ID: 11431366
[TBL] [Abstract][Full Text] [Related]
12. Retinoid status controls the appearance of reserve cells and keratin expression in mouse cervical epithelium.
Darwiche N; Celli G; Sly L; Lancillotti F; De Luca LM
Cancer Res; 1993 May; 53(10 Suppl):2287-99. PubMed ID: 7683571
[TBL] [Abstract][Full Text] [Related]
13. Altered expression of insulin-like growth factor I and its receptor during multistage carcinogenesis in mouse skin.
Rho O; Bol DK; You J; Beltrán L; Rupp T; DiGiovanni J
Mol Carcinog; 1996 Oct; 17(2):62-9. PubMed ID: 8890954
[TBL] [Abstract][Full Text] [Related]
14. Human keratin-1.bcl-2 transgenic mice aberrantly express keratin 6, exhibit reduced sensitivity to keratinocyte cell death induction, and are susceptible to skin tumor formation.
Rodríguez-Villanueva J; Greenhalgh D; Wang XJ; Bundman D; Cho S; Delehedde M; Roop D; McDonnell TJ
Oncogene; 1998 Feb; 16(7):853-63. PubMed ID: 9484776
[TBL] [Abstract][Full Text] [Related]
15. Altered regulation of growth and expression of differentiation-associated keratins in benign mouse skin tumors.
Huitfeldt HS; Heyden A; Clausen OP; Thrane EV; Roop D; Yuspa SH
Carcinogenesis; 1991 Nov; 12(11):2063-7. PubMed ID: 1718620
[TBL] [Abstract][Full Text] [Related]
16. Dissociation of sensitivities to tumor promotion and progression in outbred and inbred SENCAR mice.
Gimenez-Conti IB; Bianchi AB; Fischer SM; Reiners JJ; Conti CJ; Slaga TJ
Cancer Res; 1992 Jun; 52(12):3432-5. PubMed ID: 1375869
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of plasminogen activator inhibitor type 2 in basal keratinocytes enhances papilloma formation in transgenic mice.
Zhou HM; Bolon I; Nichols A; Wohlwend A; Vassalli JD
Cancer Res; 2001 Feb; 61(3):970-6. PubMed ID: 11221892
[TBL] [Abstract][Full Text] [Related]
18. Deregulated minichromosomal maintenance protein MCM7 contributes to oncogene driven tumorigenesis.
Honeycutt KA; Chen Z; Koster MI; Miers M; Nuchtern J; Hicks J; Roop DR; Shohet JM
Oncogene; 2006 Jul; 25(29):4027-32. PubMed ID: 16518415
[TBL] [Abstract][Full Text] [Related]
19. Changes in keratin expression during malignant progression of transformed mouse epidermal keratinocytes.
Caulín C; Bauluz C; Gandarillas A; Cano A; Quintanilla M
Exp Cell Res; 1993 Jan; 204(1):11-21. PubMed ID: 7677983
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL
Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
